Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase 4 2Phase 3 1Phase 2/3 1Phase 1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Liver Neoplasms 4Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Neoplasms 1Klatskin Tumor 1Esophageal Neoplasms 1Cancer Pain 1Bile Duct Neoplasms 1Agnosia 1

Interventions

Capecitabine 13Fluorouracil 11Oxaliplatin 10Bevacizumab 9Leucovorin 6Irinotecan 6HMPL-013 4Folfox protocol 4Cetuximab 4ferric carboxymaltose 3regorafenib 2gadolinium ethoxybenzyl DTPA 2gadobenic acid 2Triamcinolone 2Standard of Care 2Radiofrequency Ablation 2Pirinitramide 2Morphine 2Esomeprazole 2Analgesia, Epidural 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1sodium phosphate 1raltitrexed 1polyethylene glycol 3350 1iron isomaltoside 1000 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1gadoteridol 1gadoterate meglumine 1gadodiamide 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Colorectal Neoplasms × Radiofrequency Ablation × Clear all
NCT03127072 2017-04-25

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Fudan University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn
Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡